Tradestie Institutional Equity Comparison Engine
BGM vs GLPG โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
GLPG Overall Edge
GLPG Captures Institutional Edge (3โ1 Pillars ยท 8โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Galapagos NV (GLPG) driven by superior Valuation, Growth & Margin, Options & Structure while BGM counters with relative strength in Momentum & Technical. Fundamentally, BGM trades at N/M Forward P/E with -23.4% operating margin (+69.8% YoY revenue) versus GLPG at N/M Forward P/E and 88.0% operating margin (+1093.2% YoY). In options structure, BGM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GLPG sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
GLPG
BGM N/M vs GLPG N/M Fwd P/E
Growth & Margin Winner
GLPG
Op Margin -23.4% vs 88.0% ยท YoY +69.8% vs +1093.2%
Momentum & Technical Winner
BGM
1Y -17.5% vs +5.6% ยท 52W Pos 74% vs 23%
Options & Structure Winner
GLPG
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (2nd %ile IV)
BGM
NASDAQ
BGM Group Ltd. Class A Ordinary Shares
Pharmaceutical Preparations
$8.00
-1.6% 1D
Market Cap
$108.6M
1M Return
-21.57%
1Y Return
-17.53%
Forward P/E
N/M
Unified AI Score
59.6 / 100
HOLD
Tech 65.0
Fund 55.0
Flow 50.0
Mom 50.0
GLPG
NASDAQ
Galapagos NV
Pharmaceutical Preparations
$27.73
-3.75% 1D
Market Cap
$1.9B
1M Return
-4.02%
1Y Return
+5.56%
Forward P/E
N/M
Unified AI Score
61.5 / 100
BUY
Tech 45.0
Fund 52.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BGM -17.53%
GLPG +5.56%
Spread: +85.0 pp (GLPG Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BGM TTM Op. Margin: -23.4%
GLPG TTM Op. Margin: 88.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BGM vs GLPG. Trailing 12-month operating profitability (BGM -23.4% vs GLPG 88.0%) and valuation multiples (BGM N/M vs GLPG N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BGM | GLPG | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $108.6M | $1.9B | Larger Scale | GLPG |
| Trailing P/E Ratio Valuation | N/M | 5.1x | Lower Multiple | GLPG |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +69.8% | +1093.2% | Higher Growth | GLPG |
| Operating Margin (TTM) Profitability | -23.4% | 88.0% | Higher Margin | GLPG |
| Net Profit Margin Profitability | -44.2% | 28.8% | Higher Margin | GLPG |
| Return on Equity (ROE) Capital Efficiency | -7.4% | 10.4% | Higher ROE | GLPG |
| 52-Week Range Position Momentum | 74% ($0โ$11) | 23% ($25โ$38) | Stronger Trend | BGM |
| Beta / 30D Volatility Risk Regime | 3.69ฮฒ ยท 80% Vol | 0.71ฮฒ ยท 20% Vol | Lower Realized Risk | GLPG |
| Unified Institutional Score Composite Signal | 59.6 / 100 (HOLD) | 61.5 / 100 (BUY) | Higher Composite | GLPG |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BGM vs GLPG Buy Guide
BGM
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
GLPG
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
2nd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BGM nor GLPG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.